Search

everythinglearnresearchcommunity

for

Search:↓

Different harmful mutations in the CDH3 gene cause HJMD, but symptoms vary among individuals.

The research provides specific measurements for hair follicles that can improve hair transplant and regeneration techniques.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

IGF-1 may affect hair growth and loss, but more research is needed to confirm effective and safe treatments.

Dermatologists play a key role in identifying and documenting signs of abuse and injury for forensic investigations.

P-cadherin is important for hair growth and health, and its problems can cause hair and skin disorders.

Androgen receptors found in monkey scalps, similar to humans, affect hair growth.

A new method using visual aids to diagnose hair diseases was effective after brief training.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Scalp areas that look normal in people with hair loss may still show signs of disease under a microscope.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Histopathology is not reliable for detecting early fibrosis in traction alopecia or for showing how severe it is.

Hair transplantation techniques have improved over time, leading to natural-looking results and high graft survival rates, making it a popular treatment for hair loss.

Combining oral isotretinoin and rifampicin effectively treats folliculitis decalvans.

Sporadic trichoblastic neoplasms generally don't recur or spread, with one case showing a specific genetic fusion.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

A device was made in 2008 to measure hair loss severity. Other findings include: frizzy mutation in mice isn't related to Fgfr2, C/EBPx marks preadipocytes, Cyclosporin A speeds up hair growth in mice, blocking plasmin and metalloproteinases hinders healing, hyperbaric oxygen helps ischemic wound healing, amniotic membranes heal wounds better than polyurethane foam, rhVEGF165 from a fibrin matrix improves tissue flap viability and induces VEGF-R2 expression, and bFGF enhances wound healing and reduces scarring in rabbits.

The dermatology book is useful but has some organizational issues.

Stem cell plasticity is crucial for wound healing but can also contribute to cancer development.

Dermal exosomes with miR-218-5p boost hair growth by controlling β-catenin signaling.

Wnt1a-conditioned medium from stem cells helps activate cells important for hair growth and can promote hair regrowth.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

Hair loss in male pattern baldness involves muscle degeneration and increased scalp fat.

Prominin-1 expressing cells in the dermal papilla help regulate hair follicle size and communication but don't aid in skin repair.

Placental growth factor may help treat hair loss.

Colchicine can inhibit hair growth by affecting cell activity and protein expression in hair follicles.